Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Lixte Biotechnology Holdings ( (LIXT) ).
On September 10, 2025, LIXTE Biotechnology Holdings announced a $2.6 million investment in cryptocurrencies, purchasing 10.5 Bitcoin and 300 Ethereum. This move aims to diversify its treasury holdings and facilitate potential acquisitions, with cryptocurrencies now comprising 43.6% of its treasury. The company’s board has approved increasing this allocation up to 50%, reflecting a strategic shift towards digital assets to enhance adaptability and growth in the digital economy.
More about Lixte Biotechnology Holdings
LIXTE Biotechnology Holdings, Inc. is a clinical-stage pharmaceutical company focused on developing new cancer drug targets and therapies. Its lead compound, LB-100, is a PP2A inhibitor that has shown potential in enhancing chemotherapies and immunotherapies, with ongoing clinical trials for various cancers.
Average Trading Volume: 2,135,959
Technical Sentiment Signal: Sell
Current Market Cap: $22.62M
For detailed information about LIXT stock, go to TipRanks’ Stock Analysis page.